Lansoprazole
Lansoprazole delayed-release orally disintegrating tablets are a proton pump inhibitor (PPI) indicated for the: Treatment of active duodenal ulcer in adults. (1.1) Eradication of H…
Lansoprazole delayed-release orally disintegrating tablets are a proton pump inhibitor (PPI) indicated for the: Treatment of active duodenal ulcer in adults. (1.1) Eradication of H…
Carefully consider the potential benefits and risks of etodolac extended-release tablets and other treatment options before deciding to use etodolac extended-release tablets. Use the…
Cyanocobalamin is indicated for vitamin B 12 deficiencies due to malabsorption which may be associated with the following conditions: Addisonian (pernicious) anemia. Gastrointestinal…
Propranolol hydrochloride tablets are indicated in the management of hypertension. It may be used alone or used in combination with other antihypertensive agents, particularly a thiazide…
Atomoxetine is a selective norepinephrine reuptake inhibitor indicated for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD). (1.1) 1.1 Attention-Deficit/Hyperactivity…
As a leading independent provider of trustworthy medication information, we source our database directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. RxDrugLabels.com provides the full prescription-only subset of the FDA's repository. Medication information provided here is not intended as a substitute for direct consultation with a qualified health professional.
Terms of Use | Copyright © 2024. All Rights Reserved.